Back to Journals » OncoTargets and Therapy » Volume 11
RETRACTED ARTICLE: MYO5A inhibition by miR-145 acts as a predictive marker of occult neck lymph node metastasis in human laryngeal squamous cell carcinoma
Authors Zhao X , Zhang W, Ji W
Received 4 February 2018
Accepted for publication 26 April 2018
Published 21 June 2018 Volume 2018:11 Pages 3619—3635
DOI https://doi.org/10.2147/OTT.S164597
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr William C. Cho
This paper has been retracted.
Zhao X, Zhang W, Ji W. Onco Targets Ther. 2018;11:3619–3635.
We, the Editors and Publisher of OncoTargets and Therapy, have retracted the following article.
Since publication, concerns have been raised about the integrity of the data in the article. This includes the duplication of images in Figures 2 and 3. Specifically,
- The western blot images for Figure 2A and 2C, β-actin, have been duplicated.
- The images for Figure 3C, Invasion and Migration, Mimic, have been duplicated.
When approached for an explanation, the authors did not respond to our queries, nor did they provide original data for their study. As the findings could not be verified the Editor and Publisher made the decision to retract the article and the authors were notified of this.
We have been informed in our decision-making by our editorial policies and COPE guidelines.
The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.
© 2018 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.